Canada Communicable Disease Report最新文献

筛选
英文 中文
Résumé de la déclaration du CCNI sur les recommandations au niveau de la santé publique sur l'utilisation des vaccins contre le pneumocoque chez les adultes, y compris l'utilisation des vaccins conjugués 15-valent et 20-valent NACI关于成人肺炎球菌疫苗使用的公共卫生建议的声明摘要,包括使用15价和20价结合疫苗
Canada Communicable Disease Report Pub Date : 2023-03-08 DOI: 10.14745/ccdr.v49i23a08f
Aleksandra Wierzbowski, Robert Pless, K. Hildebrand
{"title":"Résumé de la déclaration du CCNI sur les recommandations au niveau de la santé publique sur l'utilisation des vaccins contre le pneumocoque chez les adultes, y compris l'utilisation des vaccins conjugués 15-valent et 20-valent","authors":"Aleksandra Wierzbowski, Robert Pless, K. Hildebrand","doi":"10.14745/ccdr.v49i23a08f","DOIUrl":"https://doi.org/10.14745/ccdr.v49i23a08f","url":null,"abstract":"","PeriodicalId":33496,"journal":{"name":"Canada Communicable Disease Report","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46732962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Veille bibliographique de la COVID-19 – cadre pour gérer la littérature et appuyer la prise de décisions fondées sur des données probantes sur un sujet de santé publique en évolution rapide COVID-19书目监测——管理文献和支持快速变化的公共卫生主题循证决策的框架
Canada Communicable Disease Report Pub Date : 2023-01-24 DOI: 10.14745/ccdr.v49i01a02f
Tricia Corrin, Dima Ayache, Austyn Baumeister, Kaitlin Young, Kusala Pussegoda, Rukshanda Ahmad, Lisa Waddell
{"title":"Veille bibliographique de la COVID-19 – cadre pour gérer la littérature et appuyer la prise de décisions fondées sur des données probantes sur un sujet de santé publique en évolution rapide","authors":"Tricia Corrin, Dima Ayache, Austyn Baumeister, Kaitlin Young, Kusala Pussegoda, Rukshanda Ahmad, Lisa Waddell","doi":"10.14745/ccdr.v49i01a02f","DOIUrl":"https://doi.org/10.14745/ccdr.v49i01a02f","url":null,"abstract":"","PeriodicalId":33496,"journal":{"name":"Canada Communicable Disease Report","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49051850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nouveau traitement oral de six mois contre la tuberculose pré-ultrarésistante aux médicaments au Canada : les nouvelles options de traitement présentent de nouveaux défis de mise en œuvre 加拿大新的6个月口服预超耐药结核病治疗:新的治疗方案带来了新的实施挑战
Canada Communicable Disease Report Pub Date : 2023-01-24 DOI: 10.14745/ccdr.v49i01a04f
William Connors, Cesilia Nishi, Inna Sekirov, Victoria Cook, J. Johnston
{"title":"Nouveau traitement oral de six mois contre la tuberculose pré-ultrarésistante aux médicaments au Canada : les nouvelles options de traitement présentent de nouveaux défis de mise en œuvre","authors":"William Connors, Cesilia Nishi, Inna Sekirov, Victoria Cook, J. Johnston","doi":"10.14745/ccdr.v49i01a04f","DOIUrl":"https://doi.org/10.14745/ccdr.v49i01a04f","url":null,"abstract":"","PeriodicalId":33496,"journal":{"name":"Canada Communicable Disease Report","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44006750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapport national de mi-saison sur la grippe, 2022–2023 : apparition rapide et précoce d'une épidémie 2022 - 2023年国家流感中期报告:流行病的早期和早期爆发
Canada Communicable Disease Report Pub Date : 2023-01-24 DOI: 10.14745/ccdr.v49i01a03f
Myriam Ben Moussa, Steven Buckrell, Abbas Rahal, Kara Schmidt, L. Lee, N. Bastien, C. Bancej
{"title":"Rapport national de mi-saison sur la grippe, 2022–2023 : apparition rapide et précoce d'une épidémie","authors":"Myriam Ben Moussa, Steven Buckrell, Abbas Rahal, Kara Schmidt, L. Lee, N. Bastien, C. Bancej","doi":"10.14745/ccdr.v49i01a03f","DOIUrl":"https://doi.org/10.14745/ccdr.v49i01a03f","url":null,"abstract":"","PeriodicalId":33496,"journal":{"name":"Canada Communicable Disease Report","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44713916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La rage chez un chien importé, Ontario, Canada, 2022 进口犬狂犬病,加拿大安大略省,2022年
Canada Communicable Disease Report Pub Date : 2023-01-24 DOI: 10.14745/ccdr.v49i01a01f
Paul Di Salvo, Maureen Anderson, Christine Fehlner-Gardiner, Francesca Di Mauro, Howard K. Shapiro, Anna Miranda, Heather McClinchey
{"title":"La rage chez un chien importé, Ontario, Canada, 2022","authors":"Paul Di Salvo, Maureen Anderson, Christine Fehlner-Gardiner, Francesca Di Mauro, Howard K. Shapiro, Anna Miranda, Heather McClinchey","doi":"10.14745/ccdr.v49i01a01f","DOIUrl":"https://doi.org/10.14745/ccdr.v49i01a01f","url":null,"abstract":"","PeriodicalId":33496,"journal":{"name":"Canada Communicable Disease Report","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48538129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Épidémiologie de la coqueluche au Canada, 2005 à 2019 2005年至2019年加拿大百日咳流行病学
Canada Communicable Disease Report Pub Date : 2023-01-24 DOI: 10.14745/ccdr.v49i01a05f
Disha Bhagat, M. Saboui, Grace Huang, Francesca Reyes Domingo, S. Squires, Marina I. Salvadori, Y. A. Li
{"title":"Épidémiologie de la coqueluche au Canada, 2005 à 2019","authors":"Disha Bhagat, M. Saboui, Grace Huang, Francesca Reyes Domingo, S. Squires, Marina I. Salvadori, Y. A. Li","doi":"10.14745/ccdr.v49i01a05f","DOIUrl":"https://doi.org/10.14745/ccdr.v49i01a05f","url":null,"abstract":"","PeriodicalId":33496,"journal":{"name":"Canada Communicable Disease Report","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43499984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extensive SARS-CoV-2 testing reveals BA.1/BA.2 asymptomatic rates and underreporting in school children 广泛的SARS-CoV-2检测显示BA.1/BA。2 .学龄儿童无症状率和漏报率
Canada Communicable Disease Report Pub Date : 2023-01-18 DOI: 10.1101/2023.01.15.23284579
M. Martignoni, Z. Mohammadi, J. Loredo-Osti, A. Hurford
{"title":"Extensive SARS-CoV-2 testing reveals BA.1/BA.2 asymptomatic rates and underreporting in school children","authors":"M. Martignoni, Z. Mohammadi, J. Loredo-Osti, A. Hurford","doi":"10.1101/2023.01.15.23284579","DOIUrl":"https://doi.org/10.1101/2023.01.15.23284579","url":null,"abstract":"Case underreporting during the COVID-19 pandemic has been a major challenge to the planning and evaluation of public health responses. Inconsistent underreporting can undermine effective risk assessment due to high uncertainty in predicted future scenarios. Underreporting rates have been particularly high among children and youth, given that asymptomatic school children were often considered a less vulnerable population. In January 2022, the Canadian province of Newfoundland and Labrador (NL) was experiencing an Omicron variant outbreak (BA.1/BA.2 subvariants) and public health officials recommended that all students returning to elementary, junior high, and high schools (~59,452 students) complete two rapid antigen tests (RATs) to be performed three days apart. To estimate the prevalence of SARS-CoV-2, we asked parents and guardians to report the results of the RATs completed by K-12 students using an online survey, and to specify the students' school level and if students with positive RAT results had symptoms. When comparing the survey responses with the number of cases and tests reported by the NL testing system, we found that 1 out of every 4.3 (3.1-5.3) positive households were captured by provincial case count, with 5.1% positivity estimated from the RAT results, and 1.2% positivity reported by the provincial testing system. The survey data indicate that a higher percentage of SARS-CoV-2 cases were found in elementary schools, with 62.9% of positive cases (95% CI: 44.3%, 83.0%) reported from elementary school students, and the remaining 37.1% (95% CI: 22.7%, 52.9%) reported from junior high and high school students. Asymptomatic infections were 59.8% of the positive cases, with no significant difference between asymptomatic rates in elementary schools (60.8%) or in junior high and high schools (58.1%). Given the low survey participation rate (3.5%), our results may suffer from sample selection biases, and should be interpreted with caution. Nonetheless, our estimate of the underreporting ratio is consistent with ratios calculated from serology data, and our study provides insights into infection prevalence and asymptomatic infections in school children, a currently understudied population.","PeriodicalId":33496,"journal":{"name":"Canada Communicable Disease Report","volume":"47 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79115490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Pertussis epidemiology in Canada, 2005-2019. 2005-2019年加拿大百日咳流行病学
Canada Communicable Disease Report Pub Date : 2023-01-05 DOI: 10.14745/ccdr.v49i01a05
Disha Bhagat, Myriam Saboui, Grace Huang, Francesca Reyes Domingo, Susan G Squires, Marina I Salvadori, Y Anita Li
{"title":"Pertussis epidemiology in Canada, 2005-2019.","authors":"Disha Bhagat,&nbsp;Myriam Saboui,&nbsp;Grace Huang,&nbsp;Francesca Reyes Domingo,&nbsp;Susan G Squires,&nbsp;Marina I Salvadori,&nbsp;Y Anita Li","doi":"10.14745/ccdr.v49i01a05","DOIUrl":"https://doi.org/10.14745/ccdr.v49i01a05","url":null,"abstract":"<p><strong>Background: </strong>Pertussis, also known as whooping cough, is an endemic vaccine-preventable disease that affects the respiratory tract and is caused by the bacterium <i>Bordetella pertussis</i>. Between 1999 and 2004, the adolescent booster dose of pertussis was introduced across Canada. This report describes the epidemiology of pertussis in Canada from 2005 to 2019, the period after adolescent acellular vaccination was recommended.</p><p><strong>Methods: </strong>We analyzed pertussis incidence by year, age groups, sex and geographic region using national surveillance data from the Canadian Notifiable Disease Surveillance System. Hospitalization data from the Discharge Abstract Database was used to investigate pertussis hospitalizations by sex and age. Deaths from pertussis were explored using Statistics Canada's vital statistics data. Vaccination coverage data was gathered from the 2019 Childhood National Immunization Coverage Survey and 2018-2019 Seasonal Influenza Vaccination Coverage Survey.</p><p><strong>Results: </strong>Between 2005 and 2019, there were a total of 33,481 pertussis cases with the average annual incidence rate of 6.4 cases per 100,000 population. The highest average age-specific incidence rate was among infants under one year of age (n=68.7 cases per 100,000 population). There were a total of 1,593 pertussis hospitalizations; nearly 80% of these hospitalizations were infants under one year of age. Hospitalization rates were 8.2 times higher in infants three months or younger compared to infants four to 11 months of age. There were 17 deaths; all among infants under one year of age.</p><p><strong>Conclusion: </strong>The highest morbidity and fatality of pertussis were among infants under one year of age. It is important to take measures to reduce transmission to infants who are too young to be vaccinated. Increasing vaccine coverage in children and pregnant women are important to reduce the burden of disease.</p>","PeriodicalId":33496,"journal":{"name":"Canada Communicable Disease Report","volume":"49 1","pages":"21-28"},"PeriodicalIF":0.0,"publicationDate":"2023-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902035/pdf/CCDR-49-21.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9328319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
National influenza mid-season report, 2022-2023: A rapid and early epidemic onset. 2022-2023 年全国流感季节中期报告:流行病迅速提前爆发。
Canada Communicable Disease Report Pub Date : 2023-01-05 DOI: 10.14745/ccdr.v49i01a03
Myriam Ben Moussa, Steven Buckrell, Abbas Rahal, Kara Schmidt, Liza Lee, Nathalie Bastien, Christina Bancej
{"title":"National influenza mid-season report, 2022-2023: A rapid and early epidemic onset.","authors":"Myriam Ben Moussa, Steven Buckrell, Abbas Rahal, Kara Schmidt, Liza Lee, Nathalie Bastien, Christina Bancej","doi":"10.14745/ccdr.v49i01a03","DOIUrl":"10.14745/ccdr.v49i01a03","url":null,"abstract":"<p><p>Canada's 2022-2023 national influenza epidemic was declared in epidemiological week 43 (week ending October 29, 2022), relatively early in comparison to historical seasons. This year marks the return to pre-pandemic-like influenza circulation, following the brief and delayed influenza epidemic declared in the spring of the 2021-2022 season. To date this season, 59,459 detections of influenza have been reported out of 456,536 tests; both values exceeding historical averages. This epidemic is being fundamentally driven by influenza A, with influenza A(H3N2) accounting for 94% of subtyped detections. This season to date has had a significant impact on adolescents and young children, with a high proportion of detections occurring in those aged 0-19 years (42%). Provinces and territories have reported higher than usual influenza-associated hospitalizations, intensive care unit admissions, and deaths in comparison with previous seasons; in particular, paediatric hospitalization incidence was persistently far above historical peak levels for several weeks. The return of seasonal influenza circulation highlights the importance of sustained vigilance with regard to influenza and employment of available mitigation measures, especially of annual seasonal influenza vaccination.</p>","PeriodicalId":33496,"journal":{"name":"Canada Communicable Disease Report","volume":"49 1","pages":"10-14"},"PeriodicalIF":0.0,"publicationDate":"2023-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902033/pdf/CCDR-49-10.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10766481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rabies in an imported dog, Ontario, Canada, 2022. 2022 年,加拿大安大略省,一只进口犬患狂犬病。
Canada Communicable Disease Report Pub Date : 2023-01-05 DOI: 10.14745/ccdr.v49i01a01
Paul Di Salvo, Maureen Anderson, Christine Fehlner-Gardiner, Francesca Di Mauro, Howard Shapiro, Anna Miranda, Heather McClinchey
{"title":"Rabies in an imported dog, Ontario, Canada, 2022.","authors":"Paul Di Salvo, Maureen Anderson, Christine Fehlner-Gardiner, Francesca Di Mauro, Howard Shapiro, Anna Miranda, Heather McClinchey","doi":"10.14745/ccdr.v49i01a01","DOIUrl":"10.14745/ccdr.v49i01a01","url":null,"abstract":"<p><p>Importation of rabies-infected dogs results in significant and costly public and animal health risks. In January 2022, a dog in Ontario, Canada, which was imported from Iran in June 2021, developed rabies, leading to an extensive public health investigation and administration of rabies post-exposure prophylaxis to 37 individuals. The dog was infected with a rabies virus variant known to circulate in Iran. This is the second reported case of a rabies-infected dog imported into Canada in 2021 from a high-risk country for canine mediated rabies. This case emphasizes the need for public education regarding the risks associated with importing dogs from high-risk countries for canine-mediated rabies and the benefits of establishing a public health team specializing in rabies exposure investigations.</p>","PeriodicalId":33496,"journal":{"name":"Canada Communicable Disease Report","volume":"49 1","pages":"1-4"},"PeriodicalIF":0.0,"publicationDate":"2023-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902034/pdf/CCDR-49-01.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10766480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信